NeuroMax: AI-Driven Maxillary Expander System

Publication ID: 24-11857230_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “NeuroMax: AI-Driven Maxillary Expander System,” Published Technical Disclosure No. 24-11857230_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857230_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,230.

Summary of the Inventive Concept

NeuroMax is an innovative maxillary expander system that leverages artificial intelligence, machine learning, and real-time data analysis to provide personalized, optimized treatment plans for patients with maxillary deficiencies.

Background and Problem Solved

Current maxillary skeletal anchorage expanders have limitations in terms of effectiveness, patient comfort, and treatment accuracy. The original patent, while addressing some of these issues, does not fully exploit the potential of advanced technologies to revolutionize maxillary expansion treatments. NeuroMax addresses these limitations by integrating AI-driven prediction, machine learning-based analysis, and real-time sensor feedback to provide a more efficient, accurate, and patient-centric treatment approach.

Detailed Description of the Inventive Concept

NeuroMax comprises a neural network-based prediction module that analyzes patient-specific data, including medical history, anatomical characteristics, and treatment goals. This module generates customized treatment plans, which are then executed by the maxillary expander device. The device features integrated sensors that provide real-time feedback on treatment progress, enabling the AI system to adapt and adjust the force application in real-time. Additionally, the system includes an augmented reality visualization component to guide clinicians during treatment and provide accurate feedback. The modular design of NeuroMax allows for remote monitoring, data analysis, and cloud-based updates, ensuring that clinicians have access to the latest advancements in maxillary expansion technology.

Novelty and Inventive Step

The NeuroMax system's innovative combination of AI-driven prediction, machine learning-based analysis, and real-time sensor feedback constitutes a significant departure from existing maxillary expander technologies. The integration of these advanced technologies enables a paradigm shift in maxillary expansion treatments, providing unprecedented levels of personalization, accuracy, and efficiency.

Alternative Embodiments and Variations

Alternative embodiments of NeuroMax could include variations in the AI algorithm, sensor configurations, or augmented reality visualization components. Additionally, the system could be adapted for use in other orthodontic or dental applications, such as mandibular expansion or craniofacial reconstruction.

Potential Commercial Applications and Market

NeuroMax has significant commercial potential in the orthodontic and dental industries, offering a cutting-edge solution for maxillary expansion treatments. The system's AI-driven approach, real-time feedback, and augmented reality visualization capabilities position it for widespread adoption in clinics and hospitals worldwide.

CPC Classifications

SectionClassGroup
A A61 A61B17/8071
A A61 A61B17/663
A A61 A61B17/8023
A A61 A61B17/863

Original Patent Information

Patent NumberUS 11,857,230
TitleMaxillary expander and protraction device
Assignee(s)Facegenics, Inc.